Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
As of close of business last night, Integra Lifesciences Holdings Corp’s stock clocked out at $19.19, up 6.20% from its previous closing price of $18.07. In other words, the price has increased by $6.20 from its previous closing price. On the day, 1.22 million shares were traded. IART stock price reached its highest trading level at $19.25 during the session, while it also had its lowest trading level at $16.88.
Ratios:
To gain a deeper understanding of IART’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.42 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 59.36. For the most recent quarter (mrq), Quick Ratio is recorded 0.71 and its Current Ratio is at 1.17. In the meantime, Its Debt-to-Equity ratio is 1.28 whereas as Long-Term Debt/Eq ratio is at 0.88.
On December 02, 2024, Morgan Stanley started tracking the stock assigning a Underweight rating and target price of $20.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 03 ’24 when Schwartz Eric sold 4,070 shares for $24.59 per share. The transaction valued at 100,102 led to the insider holds 59,511 shares of the business.
Schwartz Eric bought 4,070 shares of IART for $100,102 on Dec 03 ’24. On Dec 02 ’24, another insider, McBreen Michael J., who serves as the EVP & President, CSS of the company, sold 1,700 shares for $24.16 each. As a result, the insider received 41,064 and left with 56,182 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IART now has a Market Capitalization of 1482425728 and an Enterprise Value of 3223999232. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.92 while its Price-to-Book (P/B) ratio in mrq is 0.96. Its current Enterprise Value per Revenue stands at 2.002 whereas that against EBITDA is 9.985.
Stock Price History:
The Beta on a monthly basis for IART is 1.25, which has changed by -0.4211161 over the last 52 weeks, in comparison to a change of 0.049593568 over the same period for the S&P500. Over the past 52 weeks, IART has reached a high of $34.79, while it has fallen to a 52-week low of $16.81. The 50-Day Moving Average of the stock is -16.47%, while the 200-Day Moving Average is calculated to be -16.13%.
Shares Statistics:
It appears that IART traded 669.74K shares on average per day over the past three months and 649890 shares per day over the past ten days. A total of 77.17M shares are outstanding, with a floating share count of 66.12M. Insiders hold about 14.38% of the company’s shares, while institutions hold 90.45% stake in the company. Shares short for IART as of 1741910400 were 3978327 with a Short Ratio of 5.94, compared to 1739491200 on 3504670. Therefore, it implies a Short% of Shares Outstanding of 3978327 and a Short% of Float of 5.9799999999999995.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
